Complement factors and their receptors

Immunopharmacology

Volumn 38, Issue 1-2, 1997, Pages 3-15

  Ember, Julia A ^a   Hugli, Tony E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Anaphylatoxin; C3a; C3a receptor; C5a; C5a receptor

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; INFLAMMATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW;

AMINO ACID SEQUENCE; ANAPHYLATOXINS; ANAPHYLAXIS; ANTIGEN-ANTIBODY COMPLEX; CLONING, MOLECULAR; COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C4A; COMPLEMENT C5A; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; RECEPTORS, COMPLEMENT;

EID: 0031474771     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00088-X     Document Type: Review

References (84)

1. Ambrosius, D., Casaretto, M., Gerardy-Schahn, R., Saunders, D., Brandenburg, D., Zahn, H., 1989. Peptide analogues of the anaphylatoxin C3a; Syntheses and properties. Biol. Chem. Hoppe-Seyler 370, 217-227.
2. Ames, R.S., Li, Y., Sarau, H.M., Nuthulaganti, P., Foley, J.J., Ellis, C., Zeng, Z., Su, K., Jurewicz, A.J., Hertzberg, R.P., Bergsma, D.J., Kumar, C., 1996. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271, 20231-20234.
3. Amsterdam, E.A., Stahl, G.L., Pan, H.L., Rendig, S.V., Fletcher, M.P., Longhurst, J.C., 1995. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am. J. Physiol. 268, H448-H457.
4. Barnum, S.R., 1995. Complement biosynthesis in the central nervous system. Crit. Rev. Oral. Biol. Med. 6, 132-146.
5. Boulay, F., Mery, L., Tardif, M., Brouchon, L., Vignalis, P., 1991. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30, 2993-2999.
6. Buchner, R.R., Hugli, T.E., Ember, J.A., Morgan, E.L., 1995. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. J. Immunol. 155, 308-315.
7. Caporale, L.H., Tippett, P.S., Erickson, B.W., Hugli, T.E., 1980. The active site of C3a anaphylatoxin. J. Biol. Chem. 255, 10758-10763.
8. Carney, D.F., Hugli, T.E., 1993. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor. Protein Sci. 2, 1391-1399.
9. Carroll, M.C., Fischer, M.B., 1997. Complement and the immune response. Curr. Opin. Immunol. 9, 64-69.
10. Chenoweth, D.E., Hugli, T.E., 1978. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 75, 3943-3947.
11. Chenoweth, D.E., Erickson, B.W., Hugli, T.E., 1979. Human C5a-related synthetic peptides as neutrophil chemotactic factors. Biochem. Biophys. Res. Commun. 86, 227-234.
12. Chenoweth, D.E., Hugli, T.E., 1980. Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol. Immunol. 17, 151-161.
13. Crass, T., Raffetseder, U., Martin, U., Grove, M., Klos, A., Köhl, J., Bautsch, W., 1996. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26, 1944-1950.
14. DeMartino, J.A., Van Riper, G., Siciliano, S.J., Molineaux, C.J., Konteastis, Z.D., Rosen, H., Springer, M.S., 1994. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. J. Biol. Chem. 269, 14446-14450.
15. DeMartino, J.A., Konteatis, Z.D., Siciliano, S.J., Van Riper, G., Underwood, D.J., Fischer, P.A., Springer, M.S., 1995. Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs. J. Biol. Chem. 270, 15966-15969.
16. Ember, J.A., Johansen, N.L., Hugli, T.E., 1990. A new approach to designing active analogues of proteins. Biochem. Soc. Trans. 18, 1154-1155.
17. Ember, J.A., Johansen, N.L., Hugli, T.E., 1991. Designing synthetic superagonists of C3a anaphylatoxin. Biochemistry 30, 3603-3612.
18. Ember, J.A., Sanderson, S.D., Taylor, S.M., Kawahara, M., Hugli, T.E., 1992. Biologic activity of synthetic analogues of C5a anaphylatoxin. J. Immunol. 148, 3165-3173.
19. Ember, J.A., Cui, L., Carney, D.F., Pettis, R.J., Erickson, B.W., Hugli, T.E., 1993. Molecular and functional characterization of superpotent rat C5a. Protein Sci. 2 (suppl. 1), 159, abstract.
20. Ember, J.A., Morgan, E.L., Sanderson, S.D., Hugli, T.E., 1994. Anti-C5a receptor antibody inhibits biologic activity of C5a but not synthetic C5a analogues. FASEB J. 8, A500, abstract.
21. Farries, T., Atkinson, J.P., 1991. Evolution of the complement system. Immunol. Today 12, 295-300.
22. Foreman, K.E., Vaporciyan, A.A., Bonish, B.K., Jones, M.L., Glovsky, M.M., Eddy, S.M., Ward, P.A., 1994. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94, 1147-1155.
23. Frank, M.M., 1987. Complement in the pathophysiology of human disease. N. Engl. J. Med. 316, 1525-1530.
24. Frank, M.M., 1989. Complement: a brief review. J. Allergy Clin. Immunol. 84, 411-420.
25. Fukuoka, Y., Hugli, T.E., 1988. Demonstration of a specific C3a receptor on guinea pig platelets. J. Immunol. 140, 3496-3501.
26. Fukuoka, Y., Hugli, T.E., 1997a. Molecular characterization of the guinea pig and rat C3a receptor. Microcirculation 4, 121, abstract.
27. Fukuoka, Y., Ember, J.A., Hugli, T.E., 1997b. Molecular cloning of two isoforms of the guinea pig C3a receptor. J. Biol. Chem. (submitted).
28. Gardinali, M., Conciato, L., Cafaro, C., Agostoni, A., 1995. Complement system in coronary heart disease: a review. Immunopharmacology 30, 105-117.
29. Gasque, P., Chan, P., Fontaine, M., Ischenko, A., Lamacz, M., Götze, O., Morgan, B.P., 1995. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. Relevance to inflammation in the brain. J. Immunol. 155, 4882-4889.
30. Gasque, P., Singhrao, S.K., Neal, J.W., Götze, O., Morgan, B.P., 1997. Expression of the receptor for C5a (CD88) is upregulated on reactive astrocytes, microglia and endothelial cells in inflamed human CNS. Am. J. Pathol. 150, 31-41.
31. Gerard, C., Chenoweth, D.E., Hugli, T.E., 1979. Molecular aspects of the serum chemotactic factors. J. Reticuloendothel. Soc. 26, 711-718.
32. Gerard, C., Hugli, T.E., 1981a. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a. Proc. Natl. Acad. Sci. USA 78, 1833-1837.
33. Gerard, C., Chenoweth, D.E., Hugli, T.E., 1981b. Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5a-des Arg-74 but not of C5a in biologic activity. J. Immunol. 127, 1978-1982.
34. Gerard, C., Showell, H.J., Hoeprich, P.D., Hugli, T.E., Stimler, N.P., 1985. Evidence for a role of the amino terminal region in the biological activity of the classical anaphylatoxin porcine C5a des Arg-74. J. Biol. Chem. 260, 2613-2616.
35. Gerard, N.P., Gerard, C., 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-617.
36. Gerardy-Schahn, R., Ambrosius, D., Casaretto, M., Grötzinger, J., Saunders, D., Wollmer, A., Brandenburg, D.M., Bitter-Suermann, D., 1988. Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements. Biochem. J. 255, 209-216.
37. Gerardy-Schahn, R., Ambrosius, D., Saunders, D., Casaretto, M., Mittler, C., Karwarth, G., Goergen, S., Bitter-Suermann, D., 1989. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes. Eur. J. Immunol. 19, 1095-1102.
38. Giannini, E., Brouchon, L., Boulay, F., 1995. Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo. J. Biol. Chem. 270, 19166-19172.
39. Haviland, D.L., McCoy, R.L., Whitehead, W.T., Akama, H., Molmenti, E.P., Brown, A., Haviland, J.C., Parks, W.C., 1995. Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154, 1861-1869.
40. Hoeprich, P.D. Jr., Hugli, T.E., 1986. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity. Biochemistry 25, 1945-1950.
41. Hsu, M.H., Ember, J.A., Wang, M., Prossnitz, E.R., Hugli, T.E., Ye, R.D., 1997. Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene. Immunogenetics (in press).
42. Huey, R., Hugli, T.E., 1985. Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN). J. Immunol. 135, 2063-2068.
43. Huey, R., Fukuoka, Y., Hoeprich, P.D. Jr., Hugli, T.E., 1986. Cellular receptors to the anaphylatoxins C3a and C5a. Biochem. Soc. Symp. 51, 69-81.
44. Hugli, T.E., Erickson, B.W., 1977. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin. Proc. Natl. Acad. Sci. USA 74, 1826-1830.
45. Ito, B.R., Del Balzo, U., 1994. Effect of platelet depletion and inhibition of platelet cyclooxygenase on C5a-mediated myocardial ischemia. Am. J. Physiol. 267, H1288-H1294.
46. Ivey, C.L., Williams, F.M., Collins, P.D., Jose, P.J., Williams, T.J., 1995. Neutrophil chemoattractaants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8 (comment). J. Clin. Invest. 95, 2720-2728.
47. Johnston, R.B. Jr., 1993. The complement system in host defense and inflammation: the cutting edges of a double edged sword. Pediatr. Infect. Dis. 12, 933-941.
48. Johnson, R.J., Chenoweth, D.E., 1985. Labeling the granulocyte C5a receptor with a unique photoreactive probe. J. Biol. Chem. 260, 7161-7164.
49. Kalnik, M.W., Chazin, W.J., Wright, P.E., Villafranca, J.J. (Eds.), 1997. Techniques in Protein Chemistry II. The Three-Dimensional Solution Structure of Human Anaphylatoxin C3a. Academic Press, San Diego, CA, 37, pp. 393-400.
50. Kawai, M., Lane, B., Mollison, K.W., Luly, J.R., Carter, G.W., 1991a. Improved binding potency of a C5a related octapeptide by incorporation of N-methyl amino acids. 12th American Peptide Symp Cambridge, MA, #P-525 (abstract).
51. Kawai, M., Quincy, D.A., Lane, B., Mollison, K.W., Luly, J.R., Carter, G.W., 1991b. Identification and synthesis of a receptor binding site of human anaphylatoxin C5a. J. Med. Chem. 34, 2068-2071.
52. Kawai, M., Quincy, D.A., Lane, B., Mollison, K.W., Or, Y.S., Luly, J.R., Carter, G.W., 1992. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a. J. Med. Chem. 35, 220-223.
53. Kazatchkine, M.D., Carreno, M.P., 1988. Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 9, 30-35.
54. Kinoshita, T., 1991. Biology of complement: the overture. Immunol. Today 12, 291-295.
55. 125I-C3a binding. Biochemistry 31, 11274-11282.
56. Kola, A., Klos, A., Bautsch, W., Kretzschmar, T., Köhl, J., 1992. Functional activities of synthetic anaphylatoxic peptides in widely used biological assays. Clin. Exp. Immunol. 88, 368-372.
57. Köhl, J., Casaretto, M., Gier, M., Karwath, G., Gietz, C., Bautsch, W., Saunders, D., Bitter-Suermann, D., 1990. Reevaluation of the C3a active site using short synthetic C3a analogues. Eur. J. Immunol. 20, 1463-1468.
58. Köhl, J., Lübbers, B., Klos, A., Bautsch, W., Casaretto, M., 1993. Evaluation of the C-terminal C5a effector site with short synthetic C5a analog peptides. Eur. J. Immunol. 23, 646-652.
59. Kretzschmar, T., Pohl, M., Casaretto, M., Przewosny, M., Bautsch, W., Klos, A., Saunders, D., Köhl, J., 1992. Synthetic peptides as antagonists of the anaphylatoxin C3a. Eur. J. Biochem. 210, 185-191.
60. Lachmann, P.J., 1990. Protection against complement lysis. Biochem. Soc. Trans. 18, 1159-1160.
61. Lu, Z.X., Fok, K.-F., Erickson, B.W., Hugli, T.E., 1984. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide. J. Biol. Chem. 259, 7367-7370.
62. Mery, L., Boulay, F., 1994. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. J. Biol. Chem. 269, 3457-3463.
63. Moffitt, M.C., Frank, M.M., 1994. Complement resistance in microbes. Springer Semin. Immunopathol. 15, 327-344.
64. Mollison, K.W., Mandecki, W., Zuiderweg, E.R.P., Fayer, L., Fey, T.A., Krause, R.A., Conway, R.G., Miller, R.G., Edalji, L., Shallcross, M.A., Lane, B., Fox, J.L., Greer, J., Carter, G.W., 1989. Identification of receptor-binding residues in the inflammatory complement protein C5a site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 86, 292.
65. Monk, P.N., Barker, M.D., Partridge, L.J., Pease, J.E., 1995. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus. J. Biol. Chem. 270, 16625-16629.
66. Morgan, E.L., Sanderson, S., Scholz, W., Noonan, D.J., Weigle, W.O., Hugli, T.E., 1992. Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J. Immunol. 148, 3937-3942.
67. Morgan, E.L., Ember, J.A., Sanderson, S.D., Scholz, W., Buchner, R., Ye, R.D., Hugli, T.E., 1993. Anti-C5a Receptor Antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. J. Immunol. 151, 377-388.
68. Mulligan, M.S., Schmid, E., Till, G.O., Friedl, H.P., Hugli, T.E., Johnson, K.J., Ward, P.A., 1996. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98, 503-512.
69. Mulligan, M.S., Schmid, E., Till, G.O., Hugli, T.E., Friedl, H.P., Roth, R.A., Ward, P.A., 1997. C5a-dependent upregulation in vivo of lung vascular P-selectin. J. Immunol. 158, 1857-1861.
70. Müller-Eberhard, H.J., 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57, 321-347.
71. 2+ influx in neutrophils via a pertussis-toxin-sensitive G protein. Eur. J. Biochem. 217, 289-294.
72. Oppermann, M., Raedt, U., Hebell, T., Schmidt, B., Zimmermann, B., Götze, O., 1993. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies: Identification of a potential ligand binding site on the NH-2-terminal domain. J. Immunol. 151, 3785-3794.
73. Or, Y.S., Clark, B., Lane, B., Mollison, K.W., Carter, G.W., Luly, J.R., 1992. Improvements in the minimum binding sequence of C5a: examination of His 67. J. Med. Chem. 35, 402-406.
74. Pease, J.E., Barker, M.D., 1993. N-linked glycosylation of the C5a receptor. Biochemistry 31, 719-726.
75. Pease, J.E., Burton, D.R., Barker, M.D., 1994. Generation of chimeric C5a/formyl peptide receptors: towards the identification of the human C5a receptor binding site. Eur. J. Immunol. 24, 211-215.
76. Reid, K.B., 1986. Activation and control of the complement system. Essays Biochem. 22, 27-68.
77. Roglic, A., Prossnitz, E.R., Cavanagh, S.L., Pan, Z., Zou, A., Ye, R.D., 1996. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim. Biophys. Acta 1305, 39-43.
78. Rollins, T.E., Springer, M.S., 1985. Identification of the polymorphonuclear leukocyte C5a receptor. J. Biol. Chem. 260, 7157-7160.
79. Rother, K., Rother, U., 1986. Biological functions of the complement system. Prog. Allergy 39, 24-100.
80. Schmid, E., Warner, R.L., Crouch, L.D., Friedl, H.P., Till, G.O., Hugli, T.E., Ward, P.A., 1997. Neutrophil chemotactic activity and C5a following systemic activation of complement in rats. Inflammation (in press).
81. Siciliano, S.J., Rollins, T.E., DeMartino, J., Konteatis, Z., Malkowitz, L., Van Riper, G., Bondy, S., Rosen, H., Springer, M.S., 1994. Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 91, 1214-1218.
82. Tempero, R.M., Hollingsworth, M.A., Burdick, M.D., Finch, A.M., Taylor, S.M., Vogen, S.M., Morgan, E.L., Sanderson, S.D., 1997. Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin. J. Immunol. 158, 1377-1382.
83. Tornetta, M.A., Foley, J.J., Sarau, H.M., Ames, R.S., 1997. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization and functional expression. J. Immunol. 158, 5277-5282.
84. Ward, P.A., 1996. Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. Am. J. Pathol. 149, 1081-1086.